Icon

Myrbetriq Granules - (8 mg/mL ; Granules for Extended-release Suspension)

Mirabegron Astellas
8 mg/mL ; Granules for Extended-release Suspension
Less Than $1000 mn
None None
Less Than 5
None
None None
MYRBETRIQ Granules is a beta-3 adrenergic agonist indicated for the treatment of NDO in pediatric patients aged 3 years and older.
Yes
Myrbetriq Granules Patent 1 Patent 2 Patent 3 Patent 4
******* *******
  1. *** **, **** : * **** ** ** ***** *** ***** ** *** ***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.